CellSource Co., Ltd. (TYO:4880)

CellSource Income Statement

Financials in millions JPY. Fiscal year is November - October.

Fiscal Year	TTM	FY 2025	FY 2023	FY 2022
Period Ending	Jan 31, 2026	Oct 31, 2025	Oct 31, 2023	Oct 31, 2022
Revenue	3,722	3,711	4,511	4,274
Revenue Growth (YoY)	-18.47%	-17.73%	5.54%	-
Cost of Revenue	1,591	1,624	1,326	1,210
Gross Profit	2,130	2,087	3,185	3,064
Selling, General & Admin	1,842	1,920	1,136	812.85
Research & Development	-	-	72.45	87.56
Other Operating Expenses	-	-	733.79	575.73
Operating Expenses	1,842	1,920	1,963	1,493
Operating Income	288.8	167	1,222	1,571
Interest Expense	-1	-1	-0.38	-0.01
Interest & Investment Income	-	-	0.01	0.01
Earnings From Equity Investments	-	-	-3.08	-3.16
Currency Exchange Gain (Loss)	-	-	-8.4	20.63
Other Non Operating Income (Expenses)	-1.79	-1	-13.58	4.67
EBT Excluding Unusual Items	286.01	165	1,196	1,593
Gain (Loss) on Sale of Investments	-13	-13	33	-9.55
Gain (Loss) on Sale of Assets	1.15	2	-	-
Other Unusual Items	-45.22	-45	10.6	-
Pretax Income	217.28	109	1,240	1,584
Income Tax Expense	128.2	99	316.54	565.8
Net Income	89.08	10	923.14	1,018
Net Income to Common	89.08	10	923.14	1,018
Net Income Growth	-89.61%	-98.92%	-9.30%	-
Shares Outstanding (Basic)	20	20	19	19
Shares Outstanding (Diluted)	20	20	19	19
Shares Change (YoY)	2.03%	3.29%	0.25%	-
EPS (Basic)	4.50	0.50	48.88	54.54
EPS (Diluted)	4.50	0.50	47.93	52.98
EPS Growth	-89.81%	-98.95%	-9.53%	-
Free Cash Flow	-	290	498.62	752.89
Free Cash Flow Per Share	-	14.58	25.89	39.19
Dividend Per Share	5.000	5.000	5.000	-
Gross Margin	-	56.24%	70.61%	71.70%
Operating Margin	7.76%	4.50%	27.08%	36.76%
Profit Margin	2.39%	0.27%	20.47%	23.82%
Free Cash Flow Margin	-	7.81%	11.05%	17.62%
EBITDA	-	384	1,285	1,616
EBITDA Margin	-	10.35%	28.50%	37.82%
D&A For EBITDA	-	217	63.85	45.42
EBIT	288.8	167	1,222	1,571
EBIT Margin	-	4.50%	27.08%	36.76%
Effective Tax Rate	-	90.83%	25.53%	35.73%
Advertising Expenses	-	-	32.81	39.44

Source: S&P Global Market Intelligence. Standard template. Financial Sources.